123 related articles for article (PubMed ID: 20556695)
1. [Oncology 2010].
Wörmann B
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1339-40. PubMed ID: 20556695
[No Abstract] [Full Text] [Related]
2. Chemotherapy principles for breast, prostate, colon and lung cancer.
Keppen M
S D Med; 2010; Spec No():52-6. PubMed ID: 20397492
[No Abstract] [Full Text] [Related]
3. Genentech caps cost of cancer drug for some patients.
Pollack A
N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339
[No Abstract] [Full Text] [Related]
4. [Fundamentals and results of cytostatic chemotherapy in some of the most common solid tumors].
Brugger SA; Huber H
Acta Med Austriaca; 1999; 26(3):83-8. PubMed ID: 10520375
[TBL] [Abstract][Full Text] [Related]
5. Current perspective - trastuzumab.
Hall PS; Cameron DA
Eur J Cancer; 2009 Jan; 45(1):12-8. PubMed ID: 19042123
[TBL] [Abstract][Full Text] [Related]
6. The use of bevacizumab in colorectal, lung, breast, renal and ovarian cancer: where does it fit?
Eskens FA; Sleijfer S
Eur J Cancer; 2008 Nov; 44(16):2350-6. PubMed ID: 18789679
[TBL] [Abstract][Full Text] [Related]
7. Personalised cancer management: closer, but not here yet.
Piccart M
Ann Oncol; 2013 Aug; 24(8):1951-5. PubMed ID: 23878113
[No Abstract] [Full Text] [Related]
8. Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
De Palma R; Liberati A; Ciccone G; Bandieri E; Belfiglio M; Ceccarelli M; Leoni M; Longo G; Magrini N; Marangolo M; Roila F;
J Clin Oncol; 2008 Mar; 26(7):1033-9. PubMed ID: 18309939
[TBL] [Abstract][Full Text] [Related]
9. Favorable response to gefitinib treatment of lung adenocarcinoma with coexisting germline and somatic epidermal growth factor receptor mutations.
Chung KP; Shih JY; Yu CJ
J Clin Oncol; 2010 Dec; 28(34):e701-3. PubMed ID: 20823418
[No Abstract] [Full Text] [Related]
10. Trastuzumab: new indication. Adjuvant breast cancer treatment for a minority.
Prescrire Int; 2007 Jun; 16(89):106. PubMed ID: 17582927
[TBL] [Abstract][Full Text] [Related]
11. [New development in the treatment of breast cancer. II. Future anti-HER2 therapy].
Yamashita T; Iwata K
Gan To Kagaku Ryoho; 2009 Dec; 36(13):2551-4. PubMed ID: 20104676
[No Abstract] [Full Text] [Related]
12. Treatment of breast cancer with trastuzumab during pregnancy.
Pant S; Landon MB; Blumenfeld M; Farrar W; Shapiro CL
J Clin Oncol; 2008 Mar; 26(9):1567-9. PubMed ID: 18349415
[No Abstract] [Full Text] [Related]
13. Novel cytotoxic backbones and targeted therapies: recent data and ongoing clinical trials.
Moulder SL
Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S30-40. PubMed ID: 20805063
[TBL] [Abstract][Full Text] [Related]
14. HER2 status and benefit from adjuvant trastuzumab in breast cancer.
Paik S; Kim C; Wolmark N
N Engl J Med; 2008 Mar; 358(13):1409-11. PubMed ID: 18367751
[No Abstract] [Full Text] [Related]
15. Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?
Seidman AD
Nat Clin Pract Oncol; 2006 Apr; 3(4):178-9. PubMed ID: 16596138
[No Abstract] [Full Text] [Related]
16. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference?
Graziano F; Cascinu S
J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535
[No Abstract] [Full Text] [Related]
17. Clinical experience with anti-EGFR therapy.
Fish-Steagall A; Searcy P; Sipples R
Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):10-9. PubMed ID: 16616282
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant therapy with trastuzumab in primary breast neoplasms--findings and validity of--opinion on the competence of the Central Oncology section of the North German Society].
Huober J
Zentralbl Gynakol; 2006 Jun; 128(3):187; author reply 187-8. PubMed ID: 16812944
[No Abstract] [Full Text] [Related]
19. Adjuvant therapy in the elderly: making the right decision.
Muss HB; Biganzoli L; Sargent DJ; Aapro M
J Clin Oncol; 2007 May; 25(14):1870-5. PubMed ID: 17488985
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy of adjuvant trastuzumab is confirmed in certain breast neoplasms].
Nau JY
Rev Med Suisse; 2007 Jan; 3(94):180. PubMed ID: 17354547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
